Form Type: 4

SEC EDGAR Link
Accession Number:0001628280-21-017115
Date:2021-08-16
Issuer: BELLICUM PHARMACEUTICALS, INC (BLCM)
Original Submission Date:

Reporting Person:

FAIR RICHARD A.
C/O BELLICUM PHARMACEUTICALS, INC.
3730 KIRBY DRIVE, SUITE 1200 HOUSTON, TX 77098

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.91 2021-08-16 deemed execution date A 265,000 (a) 2031-08-16 common stock 265,000 $2.91 265,000 direct
Footnotes
IDfootnote
f1 50% of the shares subject to the stock option vest and become exercisable on december 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.

Elevate your investments